Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Intralesional Triamcinolone and 8% Topical Pirfenidone for Treatment of Keloid Scars: 3-arm Trial

NCT02823236 is registered in ClinicalTrials.gov with Centro Dermatológico Dr. Ladislao de la Pascua as lead sponsor.

NCT NCT02823236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02823236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Intralesional Triamcinolone and 8% Topical Pirfenidone for Treatment of Keloid Scars: 3-arm Trial
Lead sponsor
Centro Dermatológico Dr. Ladislao de la Pascua
Phase
Phase 3
Overall status
Unknown status
Start date
October 24, 2016
Completion date
May 1, 2020
Enrollment
102 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

keloid